Search details
1.
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.
N Engl J Med
; 388(8): 694-705, 2023 02 23.
Article
in English
| MEDLINE | ID: mdl-36812433
2.
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.
N Engl J Med
; 386(11): 1013-1025, 2022 03 17.
Article
in English
| MEDLINE | ID: mdl-35294811
3.
First study of extended half-life rFVIIIFc in previously untreated patients with hemophilia A: PUPs A-LONG final results.
Blood
; 139(26): 3699-3707, 2022 06 30.
Article
in English
| MEDLINE | ID: mdl-35421219
4.
Comparative transcriptomic analysis of circulating endothelial cells in sickle cell stroke.
Ann Hematol
; 103(4): 1167-1179, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38386032
5.
Current and emerging gene therapies for haemophilia A and B.
Haemophilia
; 30 Suppl 3: 12-20, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38528615
6.
Promoting pain coping skills in haemophilia: A remote intervention integrating exercise and pain education.
Haemophilia
; 30(3): 800-808, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38523258
7.
Impaired repair properties of endothelial colony-forming cells in patients with granulomatosis with polyangiitis.
J Cell Mol Med
; 26(19): 5044-5053, 2022 10.
Article
in English
| MEDLINE | ID: mdl-36052734
8.
Haemophilia gene therapy-Update on new country initiatives.
Haemophilia
; 28 Suppl 4: 61-67, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35521726
9.
Aquatic exercise in patients with haemophilia: Electromyographic and functional results from a prospective cohort study.
Haemophilia
; 27(2): e221-e229, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33595163
10.
Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B.
Mol Ther
; 28(9): 2073-2082, 2020 09 02.
Article
in English
| MEDLINE | ID: mdl-32559433
11.
Gene Therapy for Hemophilia A. Reply.
N Engl J Med
; 386(23): 2247, 2022 06 09.
Article
in English
| MEDLINE | ID: mdl-35675187
12.
Long-term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B-YOND extension study.
Haemophilia
; 26(6): e262-e271, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32497409
13.
Longitudinal sequencing of RUNX1 familial platelet disorder: new insights into genetic mechanisms of transformation to myeloid malignancies.
Br J Haematol
; 186(5): 724-734, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31124578
14.
Gene Therapy: Paving New Roads in the Treatment of Hemophilia.
Semin Thromb Hemost
; 45(7): 743-750, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31096314
15.
Haemophilia Experiences, Results and Opportunities (HERO study) in Brazil: Assessment of the psychosocial effects of haemophilia in patients and caregivers.
Haemophilia
; 25(4): 640-650, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31115094
16.
First hemophilia B gene therapy approved: More than two decades in the making.
Mol Ther
; 31(1): 1-2, 2023 01 04.
Article
in English
| MEDLINE | ID: mdl-36528029
17.
Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients.
J Pharmacokinet Pharmacodyn
; 46(5): 427-438, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31115857
18.
Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients.
J Pharmacokinet Pharmacodyn
; 46(5): 439, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31302829
19.
Chronic pain in patients with hemophilia: Influence of kinesiophobia and catastrophizing thoughts.
Haemophilia
; 29(1): 386-389, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36446751
20.
Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial.
Haemophilia
; 24(6): e391-e394, 2018 Nov.
Article
in English
| MEDLINE | ID: mdl-30402994